Global Plasma Fractionation Market Overview 2023-2028
IMARC Group, a leading market research company, has recently releases report titled “Plasma fractionation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global Plasma fractionation market trends, size, share, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
The global plasma fractionation market size reached US$ 23.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 33.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028.
Plasma fractionation stands as an essential procedure within the pharmaceutical and medical sectors. This process entails the segregation of diverse constituents within blood plasma into separate fractions. Its significance lies in the production of a diverse array of therapies that are pivotal for patients battling various medical ailments, encompassing immune deficiencies, bleeding disorders, and neurological diseases. The core of this process hinges on the generosity of healthy individuals who voluntarily contribute their plasma, thereby supplying the foundational material for crafting medications that can save lives.
Global Plasma Fractionation Market Trends and Drivers:
The global market is witnessing robust growth, driven by several key factors. Foremost among these is the escalating utilization of plasma fractionation techniques to manufacture critical life-saving medications, including immunoglobulins, clotting factors, and albumin. These pharmaceuticals are instrumental in treating a wide spectrum of medical conditions, which solidify the market’s footing worldwide. Furthermore, the increasing prevalence of chronic diseases such as immune disorders, hemophilia, and liver diseases necessitates a continuous supply of plasma-derived treatments. This ongoing demand is acting as a strong catalyst for market expansion. Another pivotal factor propelling market growth is the burgeoning elderly population, which is inherently more susceptible to developing rare medical conditions that necessitate the use of blood-derived therapies.
Global Plasma Fractionation Market 2023-2028 Analysis and Segmentation:
Top Key Players covered in this report are: ADMA Biologics, Bio Products Laboratory Ltd., Boccard, Grifols, S.A., Hemarus Therapeutics Limited, Intas Pharmaceuticals Limited, LFB S.A., Merck Group, Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., SK Plasma Co. Ltd. and Virchow Biotech Private Limited
The report segmented the market on the basis of region, product, sector, application and end user.
Breakup by Product:
- Coagulation factor VIII
- Coagulation factor IX
Breakup by Sector:
- Private Sector
- Public Sector
Breakup by Application:
- Other Applications
Breakup by End User:
- Hospitals and Clinics
- Clinical Research Laboratories
- Academic Institutes
Breakup by Region:
- North America
- United States
- South Korea
- United Kingdom
- Latin America
- Middle East and Africa
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023- 2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800